Evidence map›Paper›PMID 40376069›Full record

ArticleFrontiers in public health2025

Current landscape of dyslipidemia-related randomized clinical trials registered on the International Clinical Trials Registry Platform.

Ling Pei, Muzhen Su, Reyihannisha Yakeya, Zhaoqian Hu, Aikedan Abudurexiti, Xiaochan Lin, Hongmei Zhao, Gulisitan Abudourexiti, Abudulimu Sidike, Xiaoli Li

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ling Pei *Department of Endocrinology and Metabolism, The First Affiliated Hospital of Jinan University, Guangzhou, China.
Muzhen Su *Department of Endocrinology, The First People's Hospital of Zhaoqing, Guangdong, China.
Reyihannisha YakeyaDepartment of Endocrinology, The First People's Hospital of Kashgar Region, Kashgar, China.
Zhaoqian HuDepartment of Endocrinology, The First People's Hospital of Kashgar Region, Kashgar, China.
Aikedan AbudurexitiDepartment of Endocrinology, The First People's Hospital of Kashgar Region, Kashgar, China.
Xiaochan LinDepartment of Endocrinology, The First People's Hospital of Kashgar Region, Kashgar, China.
Hongmei ZhaoDepartment of Endocrinology, The First People's Hospital of Kashgar Region, Kashgar, China.
Gulisitan AbudourexitiDepartment of Endocrinology, The First People's Hospital of Kashgar Region, Kashgar, China.
Abudulimu SidikeDepartment of Endocrinology, The First People's Hospital of Kashgar Region, Kashgar, China.
Xiaoli LiDepartment of Endocrinology, The First People's Hospital of Zhaoqing, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: This study elucidates the characteristics of randomized clinical trials (RCTs) related to dyslipidemia that are registered on the International Clinical Trials Registry Platform (ICTRP) to better identify research hotspots, address existing gaps, and improve clinical trial designs. Methods: This cross-sectional study included dyslipidemia-related RCTs registered on the ICTRP up to 13 August 2024. We evaluated the relevant characteristics of these RCTs and reviewed their publication status after enrollment using PubMed. Results: A total of 2,410 dyslipidemia-related RCTs were analyzed. The number of registered RCTs sharply increased in 2005 ( Conclusions: High-quality RCTs involving younger participants, women, and adherence-related outcomes were lacking. Researchers should prioritize exploring novel therapeutic strategies to improve trial publication rates.

Indexed as

DyslipidemiasRandomized Controlled Trials as TopicRegistriesAdolescentAdultCross-Sectional StudiesFemaleHumansMaleMiddle AgedYoung AdultadherencedyslipidemiaInternational Clinical Trials Registry Platformpublicationrandomized clinical trials

Identifiers

PMID40376069
PMCPMC12078241

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.